Generation of an induced pluripotent stem cell line SDPHi002-A from a patient with lung cancer
Authors:
- Dan AiDADan Ai
- Xiaomeng YangXYXiaomeng Yang
- Xinyu LiXLXinyu Li
- Ning LiuNLNing Liu
- Xuexue XieXXXuexue Xie
- Yi LiuYLYi Liu
- Wei SongWSWei Song
Open Access
- 15 April 2023
- journal article
- research article
- Published by Elsevier in Stem Cell Research
- Vol. 69
Abstract
No abstract availableFunding Information
- Natural Science Foundation of Shandong Province (ZR2020QH132)
This publication has 4 references indexed in Scilit:
- Cancer statistics in China and United States, 2022: profiles, trends, and determinantsChinese Medical Journal, 2022
- Liquid biopsy in lung cancer: significance in diagnostics, prediction, and treatment monitoringMolecular Cancer, 2022
- Establishment of human induced pluripotent stem cell line (SDQLCHi040-A) from a patient with Infantile-onset inflammatory bowel disease carrying a homozygous mutation in IL10RA geneStem Cell Research, 2021
- Establishment of a novel human iPSC line (SDQLCHi032-A) derived from a patient with primary hypertrophic osteoarthropathy caused by HPGD homozygous mutationStem Cell Research, 2021